Comparing blood thinners to prevent another stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two types of blood-thinning medicines to see which one is better at preventing another stroke in people who had a stroke without a clear cause. It may help if you had a stroke recently and have certain heart-related risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke within the last 14 days and doctors couldn't find the exact cause.
- You have at least one of these: stroke in multiple areas of the brain, a previous stroke while on blood thinners, an enlarged heart chamber, heart pumping weakness, or frequent extra heartbeats.
- You do not have a clear heart-related cause for your stroke, significant narrowing of blood vessels in the brain, or a recent bleeding event.
- You do not have severe kidney or liver problems, active bleeding, or a history of bleeding in the brain.
- You are not pregnant or breastfeeding.
- You have not had recent brain or spine surgery or injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing two blood thinners (edoxaban and apixaban) to see how they compare in preventing new brain spots on MRI after a stroke in people with atrial fibrillation. It may help you and your doctor choose the safer option.
This study compares four different blood-thinning medications (indobufen, aspirin, cilostazol, and clopidogrel) used to prevent another stroke. Researchers will look at which drug or combination works best and is safest for patients who've had a recent stroke.
This trial tests whether taking apixaban alone is as safe and effective as taking apixaban plus clopidogrel for people who have had a stroke due to atrial fibrillation and also have hardened arteries in the brain or neck. It aims to find the best way to prevent another stroke.
This study tests whether patients with atrial fibrillation (a heart rhythm disorder) who have had both a previous brain bleed and a recent stroke can safely take blood thinners to prevent future strokes. Researchers want to find the safest approach for people in this high-risk situation.
This trial tests two blood-thinning medications (sarpogrelate and clopidogrel) to see which one improves blood flow in the legs better and is safer for people who have had a stroke and also have leg pain when walking due to narrowed arteries.
This study compares two blood-thinning medicines, edoxaban and apixaban, to see which one is better at preventing strokes and bleeding in people who have both atrial fibrillation and coronary artery disease. If you're eligible, you may receive one of these standard treatments, and the trial could help find the safer option.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.